Home › Geographic Atrophy › Massachusetts
Geographic Atrophy clinical trials in Massachusetts
7 studies for Geographic Atrophy are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Ophthalmic Consultants of Boston, Boston
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Ophthalmic Consultants of Boston, Waltham
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Massachusetts Eye And Ear Infirmary, Boston
- Opthalmic Consultants of Boston, Boston
- New England Retina Consultants, PC, Springfield
- and 2 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Research Institute at New England Retina Consultants, Springfield
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Ophthalmic Consultants of Boston, Boston
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Ophthalmic Consultants of Boston, East Weymouth
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07230834Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Tallman Eye Associates, Lawrence
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.